Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Hepatitis C].

D Moradpour1, H E Blum

  • 1Abteilung Innere Medizin II, Medizinische Universitätsklinik Freiburg i. Br. Darius.Moradpour@uni-freiburg.de

Therapeutische Umschau. Revue Therapeutique
|October 2, 2004
PubMed
Summary
This summary is machine-generated.

Hepatitis C virus (HCV) infection causes liver disease. Current therapies offer limited success, but new antiviral strategies show promise for future treatment of this global health concern.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Effect of hepatitis B virus on steatosis in hepatitis C virus co-infected subjects: A multi-centre study and systematic review.

Journal of viral hepatitis·2018
Same author

Trends in hepatitis C-related mortality in Switzerland.

Journal of viral hepatitis·2017
Same author

Access to therapy and therapy outcomes in the Swiss Hepatitis C Cohort Study: a person-centred approach.

Journal of viral hepatitis·2016
Same author

[Hepatitis C: 25 years of progress with still major challenges].

Revue medicale suisse·2015
Same author

The transcription factor c-JUN/AP-1 promotes HBV-related liver tumorigenesis in mice.

Cell death and differentiation·2015
Same author

Systematic review with meta-analysis: self-expanding metal stents in patients with cirrhosis and severe or refractory oesophageal variceal bleeding.

Alimentary pharmacology & therapeutics·2015
Same journal

[Multimodal Cardiac Imaging: New Developments for Clinical Practice].

Therapeutische Umschau. Revue therapeutique·2026
Same journal

[Coronary angiography: From cardiac catheterization to advanced interventional cardiovascular imaging].

Therapeutische Umschau. Revue therapeutique·2026
Same journal

[Athlete's heart: role of cardiac imaging in the prevention of sudden cardiac death].

Therapeutische Umschau. Revue therapeutique·2026
Same journal

[Multimodal imaging in cardiac amyloidosis and cardiac sarcoidosis].

Therapeutische Umschau. Revue therapeutique·2026
Same journal

[Inflammatory Heart Disease: The Role of Multimodality Cardiac Imaging in Myocarditis and Pericarditis].

Therapeutische Umschau. Revue therapeutique·2026
Same journal

State-of-the-Art Cardiac Imaging

Therapeutische Umschau. Revue therapeutique·2026
See all related articles

Area of Science:

  • Hepatology
  • Virology
  • Infectious Diseases

Background:

  • Hepatitis C virus (HCV) infection is a major global cause of chronic liver disease, liver cirrhosis, and hepatocellular carcinoma.
  • Understanding HCV's virology, diagnosis, and treatment is crucial for managing patient outcomes.

Purpose of the Study:

  • To provide a concise review of the virology, diagnosis, and current therapy for Hepatitis C virus infection.
  • To highlight recent advancements in identifying novel antiviral targets and therapeutic strategies.

Main Methods:

  • Review of existing literature on Hepatitis C virus (HCV).
  • Analysis of standard therapy efficacy based on patient genotypes.
  • Exploration of emerging antiviral targets and treatment approaches.

Related Experiment Videos

Main Results:

  • Standard therapy with pegylated interferon-alpha and ribavirin achieves sustained virological response in 40-50% of genotype 1 patients.
  • Approximately 80% of genotype 2 or 3 infected patients achieve sustained virological response with standard therapy.
  • Novel antiviral targets and therapeutic strategies have been identified.

Conclusions:

  • Current standard therapies for Hepatitis C virus have variable efficacy depending on genotype.
  • Recent progress in antiviral research offers potential for improved future treatments.
  • New therapeutic strategies are expected to complement existing modalities for Hepatitis C management.